ANALISIS EFEKTIVITAS TERAPI ANTIRETROVIRAL PADA PASIEN HIV/AIDS RAWAT JALANDI RSUP FATMAWATI JAKARTA TAHUN 2016

  • Yusi Anggriani Fakultas Farmasi, Universitas Pancasila, Jakarta
  • Alfina Rianti Instalasi Farmasi RSUP Fatmawati, Jakarta
  • Jenny Pontoan Fakultas Farmasi, Institut Sains dan Teknologi Nasional, Jakarta
  • Yulwa Juwita Fakultas Farmasi, Universitas Pancasila, Jakarta
Keywords: HIV/AIDS, Effectiveness, Antiretroviral (ARV), CD4, Fatmawati Hospital

Abstract

The increasing of HIV/AIDS every year become a health problem in Indonesia. Patients of HIV/AIDS should use longterm Antiretroviral (ARV) therapy of antiretroviral therapy to support the success of antiretroviral therapy. The objective of this study was to know and compare the effectivity of four ARV combination. The four ARV combination are combination A (AZT+3TC+NVP), combination B (AZT+3TC+EFV), combination C (TNF+3TC+NVP), combination¬†D (TNF+3TC+EFV) base on increasing CD4. This study cohort-longitudinal design. Samples for this study were taken by total sampling using all data of HIV/AIDS outpatients at RS Fartmawati on 2016. The inclusion criteria were patients of (‚Č•17 years old), received treatment of either one of the four ARV combination, and had data of CD4 from laboratory result before and 6-12 months after the treatment. Data were taken from patients medical record and analyzed with non-parametric Kruskal Wallis-test. The study results showed of 124 patients had increased the CD4 mean >100 sel/mm3 one year after the treatment. The average rate of increment of each combination of antiretroviral therapy on a median CD4 cell count of 1 year was a combination of A (73.93), combination B (70.87), combination C (48.73), combination D (55.57) and there was a significant difference in CD4 cell gain in patients taking combination A-C (p value = 0.047), combination A-D (p value = 0.041), and combination B-D (p value = 0.045) at the evaluation on 1 year. Conclusion, combination A is more effective than combination B, D and C.

References

Direktorat Jendral Pemberantas Penyakit Menular & Penyehatan Lingkungan Kementerian Kesehatan RI., 2016, Statistik Kasus HIV/AIDS di Indonesia 2016, http://spiritia.or.id/Stats/stat2016.pdf.

Direktorat Jendral Pemberantas Penyakit Menular & Penyehatan Lingkungan Kementerian Kesehatan RI., 2014, Situasi dan Analisis HIV/AIDS di Indonesia tahun 2014.

Direktorat Jendral Pemberantas Penyakit Menular & Penyehatan Lingkungan Kementerian Kesehatan RI., 2011, Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi ARV pada Orang Dewasa. Jakarta.

Departemen Kesehatan RI., 2007, Pedoman Nasional Terapi Antiretroviral. Edisi Jedua, Jakarta.

Direktorat Jendral Pemberantas Penyakit Menular & Penyehatan Lingkungan Departemen Kesehatan RI., 2005, Pedoman Monitoring Pasien untuk Perawatan HIV dan Terapi Antiretroviral (ART), Jakarta.

Kusuma SL., 2015, Analisis Efektivitas Obat dan Efisiensi Biaya dalam Pengobatan HIV/AIDS pada Pasien yang Berobat Rawat Jalan di Klinik Seroja RSUD Gunung Jati Cirebon, Tesis, Magister Farmasi, Fakultas Farmasi Universitas Pancasila, Jakarta.

Kurnia Fitri Jamil, 2014, Profil Kadar CD4 Terhadap Infeksi Oportunistik Pada Penderita Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS) di RSUD DR. Zainoel Abidin Banda Aceh, Jurnal Kedokteran Syiah Kuala, Vol.14, No.02, 76-80.

Mariam S., 2010, Perbandingan Respon Imunologi Empat Kombinasi Antiretroviral berdasarkan Kenaikan Jumlah CD4 di Rumah Sakit Dr. H. Marzoeki Mahdi Bogor periode Maret 2006-Maret 2010, Tesis, Program Studi Ilmu Kefarmasian, Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Indonesia.

Octavianus NY., 2014, Hubungan Kondisi Medis Awal dan Faktor Eksternal Pasien HIV/AIDS saat mulai Terapi ARV tahun 2002-2012 dengan Peningkatan CD4 > 350 cell/mm3 di Klinik Amerta Yayasan Kerti Praja Denpasar, Tesis, Program Studi Ilmu Kesehatan Masyarakat Fakultas Kedokteran Universitas Udayana, Denpasar.

Patel NR., Swan K., Li X., Tachado SD., Koziel H., 2009, Impaired M. Tuberculosis-Mediated Apoptosis in Alveolar Macrophages from HIV+ Persons: Potential Role of IL-10 and BCL-3. J Leukoc Biol. Jul;86(1):53-60.

Rahmadini Y., Andrajati R., Andalusia R., 2008, Perbandingan Efikasi beberapa Kombinasi Antiretroviral pada Pasien HIV/AIDS ditinjau dari Kenaikan Jumlah CD4 Rata-rata di RSK Dharmais Jakarta Tahun 2005-2006. Majalah Ilmu Kefarmasian, Vol.V, No.02, 67-74.

Severe P., Juste MA., Ambroise A., et al., 2010, Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti, N Engl J Med. Jul 15;363(3):257-65

Suthar AB., Lawn SD., del Amo J., et al., 2012, Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: a Systematic Review and Meta-Analysis, PLoS Med. Jul;9(7):e1001270. doi: 10.1371/journal.pmed.1001270.

Yogani I., Karyadi TH., Uyainah A., Koesnoe S., 2015, Faktor-faktor yang Berhubungan dengan Kenaikan CD4 pada Pasien HIV yang mendapat Highly Active Antiretroviral Therapy dalam 6 bulan Pertama, Jurnal Penyakit Dalam Indonesia, Vol.02, No.04, 217-222.

Yuliandra Y., Nosa US., Raveinal, dan Almasdy D., 2017, Terapi Antiretroviral pada Pasien HIV/AIDS di RSUP. Dr. M. Djamil Padang: Kajian Sosiodemografi dan Evaluasi Obat, Jurnal Sains Farmasi dan Klinis, Vol.04, No.01, 1-8.

UNAIDS Global AIDS, 2016, Global AIDS response progress reporting (GARPR) estimates. p.1-2

WHO, 2010, Antiretroviral Therapy for HIV Infection in Adults and Adolescents Recommendations for a Public Health Approach 2010 Revision, http://www.who.int/hiv/pub/arv/adult2010

Published
2019-03-31
How to Cite
Anggriani, Y., Rianti, A., Pontoan, J., & Juwita, Y. (2019). ANALISIS EFEKTIVITAS TERAPI ANTIRETROVIRAL PADA PASIEN HIV/AIDS RAWAT JALANDI RSUP FATMAWATI JAKARTA TAHUN 2016. Jurnal Ilmiah Ibnu Sina, 4(1), 9 - 18. https://doi.org/10.36387/jiis.v4i1.212
Section
Artikel